Literature DB >> 34011766

Comment on: Malignant tumors of the eyelid in India: A multicenter, multizone study on clinicopathologic features and outcomes.

Ruchi Goel1, Shalin Shah1, Priyanka Golhait1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34011766      PMCID： PMC8302285          DOI： 10.4103/ijo.IJO_155_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN： 0301-4738            Impact factor:   1.848


× No keyword cloud information.
  5 in total

1.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

2.  Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.

Authors:  Ho-Seok Sa; Maria Laura Rubin; Shiqiong Xu; Jing Ning; Michael Tetzlaff; Oded Sagiv; Thomas J Kandl; Bita Esmaeli
Journal:  Br J Ophthalmol       Date:  2018-08-21       Impact factor: 4.638

3.  American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.

Authors:  Bita Esmaeli; Qasiem J Nasser; Hilda Cruz; Melissa Fellman; Carla L Warneke; Doina Ivan
Journal:  Ophthalmology       Date:  2012-02-11       Impact factor: 12.079

4.  Sebaceous gland carcinoma: Can we do better?

Authors:  Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

5.  Malignant tumors of the eyelid in India: A multicenter, multizone study on clinicopathologic features and outcomes.

Authors:  Roshmi Gupta; Anirban Bhaduri; Savari Desai; Sima Das; Vikas Menon
Journal:  Indian J Ophthalmol       Date:  2020-11       Impact factor: 1.848
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.